LALPATHLAB Dr Lal Pathlabs Ltd Company Mergers Announcement 2024 - Subsidiary Merger Dr. Lal PathLabs Ltds NCLT has approved the merger of its subsidiaries Paliwal Medicare (INR 47.44 million turnover) and Paliwal Diagnostics (INR 428.56 million turnover)..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Lal Pathlabs Ltd